Clinical Trials Directory

Trials / Unknown

UnknownNCT06322303

Effect of Cannabidiol (CBD) on Vision and Driving

Effect of Cannabidiol (CBD) Consumption on Visual Function and Driving Performance

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Universidad de Granada · Academic / Other
Sex
All
Age
18 Years – 43 Years
Healthy volunteers
Accepted

Summary

The use of cannabis with ∆9-tetrahydrocannabinol (THC) content has been shown to have negative effects on vision and driving. The use of other cannabinoids, such as cannabidiol (CBD), which is not attributed with a psychoactive effect, is increasing significantly. This project aims to investigate whether consuming CBD can negatively affect visual function by assessing a wide range of visual parameters and whether these changes may pose a risk for everyday activities such as driving.

Conditions

Interventions

TypeNameDescription
OTHERPlacebo (CBD 0%)Participants are required to vaporize placebo at 0% CBD concentration
OTHERCBD 15%Participants are required to vaporize CBD at a concentration of 15%.
OTHERCBD 30%Participants are required to vaporize CBD at a concentration of 30%.

Timeline

Start date
2023-02-01
Primary completion
2023-09-30
Completion
2025-12-31
First posted
2024-03-21
Last updated
2024-03-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06322303. Inclusion in this directory is not an endorsement.